PUBLISHER: Value Market Research | PRODUCT CODE: 1177566
PUBLISHER: Value Market Research | PRODUCT CODE: 1177566
Global Choroidal Neovascularization Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
Value Market Research deeply researched the Global Choroidal Neovascularization Market to foresee a significant growth in the industry over the upcoming years. The global choroidal neovascularization market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global choroidal neovascularization market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this choroidal neovascularization market.
The next sections of the choroidal neovascularization market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
North America - United States, Canada, and Mexico
Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC
Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America
Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below:
By Product Type
Intravenous
Intravitreal
By Type of Diagnosis
Fluorescein Angiography (FA)
Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
Others
By Treatment Type
Angiogenesis Inhibitors Injection
Photodynamic Therapy
Laser Photocoagulation
Low-dose Radiation Therapy
Surgery
By Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . CHOROIDAL NEOVASCULARIZATION - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 By Product Type
- 3.7.2 By Type of Diagnosis
- 3.7.3 By Treatment Type
- 3.7.4 By Application
- 3.7.5 By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
- 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 5.3. Market: Pre V/S Post COVID-19
- 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
- 5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY PRODUCT TYPE
- 6.1 Overview by Product Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Product Type
- 6.4 Intravenous Market by Regions
- 6.5 Intravitreal Market by Regions
7 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY TYPE OF DIAGNOSIS
- 7.1 Overview by Type of Diagnosis
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Type of Diagnosis
- 7.4 Fluorescein Angiography (FA) Market by Regions
- 7.5 Indocyanine Green (ICG) Angiography Market by Regions
- 7.6 Spectral Domain Optical Coherence Tomography (OCT) Market by Regions
- 7.7 Others Market by Regions
8 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY TREATMENT TYPE
- 8.1 Overview by Treatment Type
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Treatment Type
- 8.4 Angiogenesis Inhibitors Injection Market by Regions
- 8.5 Photodynamic Therapy Market by Regions
- 8.6 Laser Photocoagulation Market by Regions
- 8.7 Low-dose Radiation Therapy Market by Regions
- 8.8 Surgery Market by Regions
9 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY APPLICATION
- 9.1 Overview by Application
- 9.2 Historical and Forecast Data
- 9.3 Analysis by Application
- 9.4 Extreme Myopia Market by Regions
- 9.5 Malignant Myopic Degeneration Market by Regions
- 9.6 Age-Related Developments Market by Regions
10 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America
- 10.3.1. Overview, Historic and Forecast Data
- 10.3.2. North America By Segment
- 10.3.3. North America By Country
- 10.3.4. United State
- 10.3.5. Canada
- 10.3.6. Mexico
- 10.4. Europe
- 10.4.1. Overview, Historic and Forecast Data
- 10.4.2. Europe by Segment
- 10.4.3. Europe by Country
- 10.4.4. United Kingdom
- 10.4.5. France
- 10.4.6. Germany
- 10.4.7. Italy
- 10.4.8. Russia
- 10.4.9. Rest Of Europe
- 10.5. Asia Pacific
- 10.5.1. Overview, Historic and Forecast Data
- 10.5.2. Asia Pacific by Segment
- 10.5.3. Asia Pacific by Country
- 10.5.4. China
- 10.5.5. India
- 10.5.6. Japan
- 10.5.7. South Korea
- 10.5.8. Australia
- 10.5.9. Rest Of Asia Pacific
- 10.6. Latin America
- 10.6.1. Overview, Historic and Forecast Data
- 10.6.2. Latin America by Segment
- 10.6.3. Latin America by Country
- 10.6.4. Brazil
- 10.6.5. Argentina
- 10.6.6. Peru
- 10.6.7. Chile
- 10.6.8. Rest of Latin America
- 10.7. Middle East & Africa
- 10.7.1. Overview, Historic and Forecast Data
- 10.7.2. Middle East & Africa by Segment
- 10.7.3. Middle East & Africa by Country
- 10.7.4. Saudi Arabia
- 10.7.5. UAE
- 10.7.6. Israel
- 10.7.7. South Africa
- 10.7.8. Rest Of Middle East And Africa
11 . COMPETITIVE LANDSCAPE OF THE CHOROIDAL NEOVASCULARIZATION COMPANIES
- 11.1. Choroidal Neovascularization Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF CHOROIDAL NEOVASCULARIZATION INDUSTRY
- 12.1. Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Bausch Health Companies Inc.
- 12.3.1. Company Overview
- 12.3.2. Financials
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Bayer AG
- 12.4.1. Company Overview
- 12.4.2. Financials
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Gilead Sciences, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financials
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. Hoffmann-La Roche Ltd.
- 12.6.1. Company Overview
- 12.6.2. Financials
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. MaaT Pharma
- 12.7.1. Company Overview
- 12.7.2. Financials
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. Novartis AG
- 12.8.1. Company Overview
- 12.8.2. Financials
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. Pfizer Inc.
- 12.9.1. Company Overview
- 12.9.2. Financials
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Quark Pharmaceuticals Inc.
- 12.10.1. Company Overview
- 12.10.2. Financials
- 12.10.3. Products
- 12.10.4. Recent Developments
- 12.11. SBI ALApharma Co. Limited,
- 12.11.1. Company Overview
- 12.11.2. Financials
- 12.11.3. Products
- 12.11.4. Recent Developments
- 12.12. Regeneron Pharmaceuticals Inc.
- 12.12.1. Company Overview
- 12.12.2. Financials
- 12.12.3. Products
- 12.12.4. Recent Developments
- 12.13. Sanwa Kagaku Kenkyusho Co. Ltd.
- 12.13.1. Company Overview
- 12.13.2. Financials
- 12.13.3. Products
- 12.13.4. Recent Developments
- 12.14. Suzuken Co. Ltd.
- 12.14.1. Company Overview
- 12.14.2. Financials
- 12.14.3. Products
- 12.14.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product Type (USD MN)
- Intravenous Market by Geography (USD MN)
- Intravitreal Market by Geography (USD MN)
- Analysis Market by Type of Diagnosis (USD MN)
- Fluorescein Angiography (FA) Market by Geography (USD MN)
- Indocyanine Green (ICG) Angiography Market by Geography (USD MN)
- Spectral Domain Optical Coherence Tomography (OCT) Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by Treatment Type (USD MN)
- Angiogenesis Inhibitors Injection Market by Geography (USD MN)
- Photodynamic Therapy Market by Geography (USD MN)
- Laser Photocoagulation Market by Geography (USD MN)
- Low-dose Radiation Therapy Market by Geography (USD MN)
- Surgery Market by Geography (USD MN)
- Analysis by Application (USD MN)
- Extreme Myopia Market by Geography (USD MN)
- Malignant Myopic Degeneration Market by Geography (USD MN)
- Age-Related Developments Market by Geography (USD MN)
- Global Choroidal Neovascularization Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Choroidal Neovascularization Report
- Market Research Process
- Market Research Methodology
- Global Choroidal Neovascularization Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product Type
- Market Attractiveness Analysis by Type of Diagnosis
- Market Attractiveness Analysis by Treatment Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product Type (USD MN)
- Intravenous Market by Geography (USD MN)
- Intravitreal Market by Geography (USD MN)
- Global Market Analysis by Type of Diagnosis (USD MN)
- Fluorescein Angiography (FA) Market by Geography (USD MN)
- Indocyanine Green (ICG) Angiography Market by Geography (USD MN)
- Spectral Domain Optical Coherence Tomography (OCT) Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by Treatment Type (USD MN)
- Angiogenesis Inhibitors Injection Market by Geography (USD MN)
- Photodynamic Therapy Market by Geography (USD MN)
- Laser Photocoagulation Market by Geography (USD MN)
- Low-dose Radiation Therapy Market by Geography (USD MN)
- Surgery Market by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Extreme Myopia Market by Geography (USD MN)
- Malignant Myopic Degeneration Market by Geography (USD MN)
- Age-Related Developments Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
- Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
